drug discovery and development - microscope
Does Drug Discovery Require A Passionate Purposeful Commitment?
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Friday, August 29, 2014
When I sat down to speak with Glenn Gormley, M.D., Ph.D., the focus of an upcoming featuring in Life Science Leader magazine, I revealed that my father, like Gormley, was also a trained pediatrician (retired). “In the spirit of sharing,” Gormley, the senior executive officer and global head of R&D at Daiichi Sankyo said, “I'll tell you, my kids are still figuring out those initials in my name as well."...  Continue Reading..
Life Sciences editor Rob wright
What I Learned From My Favorite Pharmaceutical Executive Interview – Thus Far
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Tuesday, August 5, 2014
Although all of the interviews I’ve done over the years as Chief Editor of Life Science Leader magazine are special in their own ways, the truth is I do have a favorite, and would like to share what made it so. But first let me share some insights into many of the other interviews I have conducted over the years, as well as what I learned in the process.   Continue Reading..
reading books can be insightful for business
What Are You Reading? My Top 12 Business Books
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Monday, July 28, 2014
Motivational speaker, Bob Garner, recently posed the question to me, “What are you reading?”  That got me thinking again about Bob’s question and the amount of research that must have gone into some of the insightful business books I have read recently.  Continue Reading..
at DIA making connections and collaborations
DIA Does Not Disappoint — For The Most Part
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Wednesday, June 25, 2014
For the most part, the 2014 Drug Information Association’s (DIA) annual meeting did not disappoint. However, I do want to provide the DIA planners some constructive criticism toward making a great meeting even better next year.   Continue Reading..
Life science leader article on knowledge, insight and wisdom
Andrew Skibo’s Knowledge, Wisdom, And Insight Creates Connection With Readers
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Monday, June 23, 2014
I sat down with Andrew Skibo, regional VP of supply biologics, global engineering, and real estate at AstraZeneca (AZ), I had the rare opportunity to experience, first-hand, the subtle differences between knowledge, wisdom, and insight.   Continue Reading..
DIA Logo
Expect Some Surprises At This Year’s DIA
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Monday, June 9, 2014
DIA’s (Drug Information Association) 50th annual meeting takes place in San Diego next week – June 15 – 19. Though DIA released the FINAL program, you would be wise to expect the unexpected because life happens.  Continue Reading..
Merck's CRO Innovative relationship feedback
Reader Disputes Merck-Serono/Quintiles Collaboration As Being Game Changing
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Tuesday, June 3, 2014
In the April 2014 issue of Life Science Leader magazine, I wrote A Game-Changing Approach To CRO Collaboration. It was based on an in-person interview conducted with Annalisa Jenkins, former EVP and global head of R&D at Merck-Serono, while attending the BIO CEO & Investor conference this past February in New York City. In May I received feedback from a reader of the article disputing the collaboration as being...  Continue Reading..
bio international convention - 2014 global event for biotech
Warning: What You Need To Know, If Going To BIO!
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Wednesday, May 21, 2014
This year’s BIO International Convention will take place in San Diego from June 23 to 26. Going to BIO is like going to the Louvre in Paris or the Smithsonian Institution in Washington, D.C., because even with extensive planning, you can’t possibly see everything.       Continue Reading..
big pharma in biotechnology
Can Big Pharma Survive In A Big Biotech World?
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Thursday, May 15, 2014
If you looked up the definition for Big Pharma, you would be surprised if the explanation was not accompanied by a Pfizer logo. The company’s rise to becoming synonymous with Big Pharma began when Pfizer recognized the pharmaceutical success paradox of the 1990s — in order to turn small molecule drugs into commercial blockbuster successes, it was better to be BIG (i.e., BIG budgets, BIG mergers, and BIG sales forces).   Continue Reading..
U.S. Pharmaceutical Industry — Between A Hard Rock Of Hope And A Heartbreak
The U.S. Pharmaceutical Industry — Between A Hard Rock Of Hope And A Heartbreak
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Tuesday, April 29, 2014
At the 2014 PhRMA annual meeting he author of the Emmy Award-winning New York Times Series, Life Interrupted, delighted the audience with her response involving a bone marrow transplant with her brother as the donor. This was but one of the powerful experiences gained from attending this year’s PhRMA meeting, appropriately themed — from hope to cures.  Continue Reading..
Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL